Company Profile
NetraMark provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies globally. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. Founded in 2016 and headquartered in Toronto, Canada, NetraMark was formerly known as Nurosene Health Inc. before rebranding in February 2023.